TCM
IMPL

Towercrest Capital Management’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History

Towercrest Capital Management’s Portfolio IMPL Stock Details IMPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-50,500
Closed -$615K – 98
2021
Q3 		$615K Buy
+50,500
New +$615K 0.12% 56